Document Detail

The Meaning of Global Outcome Measures in Pain Clinical Trials: More Than Just Change in Pain Intensity.
MedLine Citation:
PMID:  23042473     Owner:  NLM     Status:  Publisher    
OBJECTIVES:: To understand the factors that contribute to patient and physician global outcome ratings and the extent to which receiving different doses of opioids or placebo might influence the importance of these factors better. METHODS:: A secondary analysis was performed using data from a prospective, multicenter, double-blind placebo-controlled, and active-controlled parallel group dose-ranging study comparing the efficacy of oxymorphone extended release (ER) 20 mg (ER20, N=121); oxymorphone ER 40 mg (ER40, N=121); oxycodone controlled release 20 mg (Oxy20, N=125); and placebo (N=124) in a sample of patients with osteoarthritis. We performed 2 regression analyses to identify the predictors of pretreatment to posttreatment improvement in patient and physician global ratings of arthritis status. RESULTS:: Improvement in global ratings of arthritis status was strongly associated with a decrease in pain intensity. Pretreatment to posttreatment improvement in physical and psychological functioning made independent contributions to the prediction of both criterion variables. DISCUSSION:: The findings underscore the importance of change in pain intensity as a key correlate of ratings of global improvement. However, pain intensity is not the only important factor. In the current sample, improvement in both physical and psychological functioning made independent contributions to improvements in ratings of osteoarthritis status, supporting global ratings as assessing multicomponent domains. Overall, the findings suggest that when a patient or physician reports that the patient is "doing better," the patient is likely reporting less pain intensity and engaging in more physical activity and feeling better emotionally.
Mark P Jensen; Wei Wang; Susan L Potts; Errol M Gould
Related Documents :
24235873 - Analgesic and anti-inflammatory studies of cyclopeptide alkaloid fraction of leaves of ...
4927813 - Controlled trial of metoclopramide in the treatment of flatulent dyspepsia.
22314263 - Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neu...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-5
Journal Detail:
Title:  The Clinical journal of pain     Volume:  -     ISSN:  1536-5409     ISO Abbreviation:  Clin J Pain     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8507389     Medline TA:  Clin J Pain     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
*Department of Rehabilitation Medicine, Harborview Medical Center, University of Washington, Seattle, WA †Department of Mathematics, University of West Chester, West Chester ‡Endo Pharmaceuticals Inc., Chadds Ford, PA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cost-effectiveness of self-management methods for the treatment of chronic pain in an aging adult po...
Next Document:  Research to encourage exercise for fibromyalgia (REEF): use of motivational interviewing, outcomes f...